U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07610486) titled 'Optimizing PreTerm Infant Ampicillin Dosing' on May 21.
Brief Summary: The goal of this clinical trial is to learn if preterm infants who are prescribed antibiotics shortly after birth can safety receive a shorter course of antibiotics (24 to 36 hours instead of 48 hours). The main questions it aims to answer are:
* Does short-course ampicillin provide high enough levels of ampicillin at 48 hours?
* Is short-course ampicillin safe for preterm infants to receive?
Preterm infants who are being prescribed ampicillin by their doctor and enroll in the study will stop ampicillin after a shorter than typical course, and researchers will ...